Collagen Type XVII (COL17A1) is the a key transmembrane collagen that helps maintain hair follicle stem cell identity and function— and its age-related decline is now recognized as a primary driver of hair thinning and shedding. A landmark 2016 study in Science by researchers at Tokyo Medical and Dental University proved that when COL17A1 degrades, hair follicle stem cells lose their grip, are eliminated through the skin surface, and follicles permanently miniaturize. This is why hair falls out more easily with age, and why most collagen supplements fail — they target Type I collagen for skin beauty, not Type XVII for hair anchoring. Understanding this single protein changes everything about how to approach scalp anti-aging and long-term hair retention.
What Is Collagen XVII? The Molecular Anchor of Your Hair
Most people know collagen as a skin-firming protein. But Collagen XVII is fundamentally different from the collagen in your face cream.
COL17A1 is a transmembrane collagen found in hair follicles. It functions as the molecular anchor that physically connects hair follicle stem cells (HFSCs) to the basement membrane .
Here is why that matters:
-
Hair follicle stem cells are responsible for regenerating every hair cycle
-
These stem cells must maintain their stem cell identity to function continuously.
-
COL17A1 is the protein that helps maintain hair follicle stem cell characteristics.
Without adequate Collagen XVII, stem cells lose their stemness. They migrate to the skin surface, terminally differentiate into cornified keratinocytes to be eliminated through the skin surface, and the follicle miniaturizes. The follicle miniaturizes. Hair thins. And eventually, it stops growing altogether.
The Landmark Research: How Tokyo Scientists Discovered Why Hair Thins With Age
In 2016, a team led by Dr. Hiroyuki Matsumura at Tokyo Medical and Dental University published a groundbreaking paper in Science that fundamentally changed our understanding of age-related hair loss.
Key findings from Matsumura et al., Science 2016:
-
In both aging mice and humans, COL17A1 expression naturally declines over time
-
As COL17A1 decreases, hair follicle stem cells enter an aged state.
-
These aged stem cells migrate upward to the epidermis and differentiate — they are effectively "eliminated" from the hair system
-
The follicles progressively miniaturize, producing thinner and weaker hair
-
When researchers forced maintenance of COL17A1 in hair follicle stem cells, it delayed follicle miniaturization and hair loss
This was a landmark discovery. It established COL17A1 as the master regulator of age-related hair thinning — not just a supporting player, but the critical control point.
The implication is profound: scalp aging is not separate from hair growth. It is what makes sustainable hair growth possible. And COL17A1 is the bridge between "scalp health" and "hair staying rooted."
Why Most Collagen Products Will Not Help Your Hair
If Collagen XVII is so important, why not just take more collagen? Unfortunately, it is not that simple.
Oral collagen supplements are broken down into individual amino acids during digestion. There is no mechanism for targeted delivery to your scalp follicles. Your body decides where those amino acids go — and your hair follicles are not at the front of the line.
Topical collagen (large molecule) sits on the skin surface. Collagen molecules are far too large to penetrate down to the follicle level where stem cells reside. It may moisturize the surface, but it never reaches where it is needed.
The real problem: Most collagen products only address Type I collagen — the type associated with general skin beauty. They miss Type XVII entirely.
The key is not adding collagen externally. It is stimulating local synthesis of Collagen XVII at the follicle microenvironment — right where stem cells need it.
From Understanding the Problem to Engineering a Solution: How Groland Approached Collagen XVII
The science is clear: COL17A1 degradation drives follicle miniaturization, oral collagen cannot reach the target, and topical collagen molecules are too large to penetrate. What the scalp needs is a molecule small enough to reach the follicle microenvironment, stable enough to survive the scalp surface, and precise enough to stimulate local COL17A1 synthesis — not just deliver collagen from outside.
This is exactly the challenge that Groland set out to solve. Built on XtalPi's AI + Robotics drug discovery platform — originally developed for pharmaceutical molecular design — Groland took a fundamentally different approach to scalp science. Instead of reformulating existing cosmetic ingredients, the team used AI-driven molecular screening to design purpose-built active compounds from the ground up, targeting the specific biological mechanisms behind scalp aging and follicle decline.
The result is Groland's proprietary "Gemini" Molecular Formula — two INCI-certified molecules that work as a dual-action system:
-
AquaKine™ Peptide (XTP-016) — A cyclic peptide engineered to stimulate local synthesis of multiple collagen types at the follicle level, including the critical Type XVII. Unlike linear peptides that degrade quickly, AquaKine's cyclic structure gives it greater stability and precision. It simultaneously addresses collagen infrastructure (anchoring), scalp barrier integrity, and chronic micro-inflammation — the three structural pillars that keep follicles healthy.
-
Remeanagen™ (XTP-118) — An AMPK agonist designed to reactivate dormant hair follicle stem cells. While AquaKine rebuilds the structural environment, Remeanagen reignites cellular energy. It triggers autophagy to clear damaged cellular components, boosts ATP production in dermal papilla cells, and pushes resting follicles from the dormant telogen phase back into active anagen growth — addressing the vitality dimension that collagen alone cannot.
Together, AquaKine and Remeanagen form an "maintain + activate" system: AquaKine rebuilds and strengthens the collagen infrastructure that holds follicle stem cells in place, while Remeanagen wakes up the stem cells themselves and fuels their growth cycle. This dual mechanism directly targets the two core failures behind age-related hair thinning — structural collapse and cellular dormancy.
Both molecules are INCI-certified, marking the first time AI-designed active ingredients have entered the global cosmetic ingredient standard. And both have been validated through independent third-party testing — the data below comes from these studies.
AquaKine™ Peptide and Collagen XVII: What the Data Shows
With the engineering approach established, here is what AquaKine Peptide actually delivers on the Collagen XVII front — measured in independent third-party lab studies:
Type XVII collagen protein expression: +75.93%
-
Model: UVB-damaged keratinocyte model
-
Measurement: Integrated Optical Density (IOD) 0.95 vs. normal control 0.54
-
Statistical significance: p < 0.01
-
Concentration tested: 0.0625%
Type XVII collagen gene expression: +17% (p < 0.05)
What makes this data remarkable is context: Groland™ Aquakine™ scalp serum is currently the only scalp serum with publicly available Type XVII collagen data. While other products claim general collagen benefits, none have published specific Collagen XVII upregulation results at the protein level.
This is not a general collagen boost. It is a targeted, measurable increase in the exact collagen type that maintains your hair follicle stem cells.
Root Anchoring Strength: From Lab to Clinical Results
Laboratory data on protein expression is important — but does it translate to real-world hair retention? Clinical testing confirms it does.
Clinical validation results:
-
Hair shedding reduction: -16.08% (14-day clinical study)
-
Hair density: +21.21% (6-week clinical study)
-
Average hairs per follicle: +9.74% (6-week clinical study)
The root anchoring result is particularly meaningful. A 16.08% reduction in hair shedding— measured in just 14 days — directly reflects the COL17A1 mechanism: stronger molecular anchoring at the stem cell-basement membrane junction translates to hair that resists shedding.
The 4-Collagen Synergy: Why XVII Alone Is Not Enough
Hair follicles do not exist in isolation. They are embedded in a complex extracellular matrix that requires multiple collagen types working together. AquaKine Peptide upregulates four key collagens simultaneously:
-
Type I: +148.78%— Structural matrix strength. The scaffolding that gives your scalp its firmness and supports follicle architecture.
-
Type III: +78.18% — Elasticity and flexibility. Ensures the scalp matrix can stretch and move without damaging follicle structures.
-
Type V: +65.91% — Fiber assembly regulation. Controls how collagen fibers organize, ensuring proper matrix architecture.
-
Type XVII: +75.93% — Stem cell anchoring. The direct connection keeping hair follicle stem cells in place.
Think of it this way: Type XVII supports stem cell identity, but Types I, III, and V build the house that the stem cells live in. You need both — the stem cells and the environment that supports them.Together, these four collagens rebuild the complete scalp collagen infrastructure from the ground up.
What This Means for You: Stronger Roots, Less Shedding, Better Hair Retention
Understanding Collagen XVII changes how you should think about hair care:
Hair follicle stem cell aging directly drives hair aging. COL17A1 decline with age triggers stem cell aging, leading to permanent stem cell loss.This is why age-related thinning is progressive.
Targeted local stimulation matters more than oral supplementation. The goal is not to flood your body with generic collagen peptides. The goal is to upregulate Collagen XVII synthesis specifically at the follicle level.
Look for data, not claims. Any product can claim "collagen support." Very few can show you Type XVII protein expression data with statistical significance. That is the standard you should demand.
When XVII degrades, stem cells detach, follicles miniaturize, and hair thins. When XVII is maintained, stem cells stay preserve their identity, follicles stay productive, and hair stays rooted. Science is clear — and now, for the first time, there is a topical approach with data to match.
References
-
AquaKine Peptide efficacy data: Type XVII collagen protein expression study, UVB-damaged keratinocyte model, 0.0625% concentration.
-
Clinical study: Root anchoring strength, 14-day protocol; Hair density, 6-week protocol.